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Cytocompatible hydrogels with good mechanical properties and predictable degradation are 
highly desired for many biomedical applications including stem cell and therapeutics delivery for 
guided tissue repair. However, existing methods for fabricating tough hydrogels usually involve 
non-physiological conditions, such as toxic starting materials, catalysts, or crosslinking 
chemistry. Moreover, precisely controlling hydrogel degradation over a broad range in a 
predictable manner has been extremely challenging while empirical tuning of most degradable 
materials’ degradation profiles often resulting in undesired changes in other properties. To solve 
these problems, we recently developed a versatile hydrogel formulation that allows us to 
fabricate cytocompatible tough hydrogels under physiological conditions with predicable and 
widely tunable degradations. This platform was based on a well-defined hydrogel network 
formed by two pairs of four-armed poly(ethylene glycol) macromers terminated with 
bioorthogonal azide and dibenzocyclooctyl endgroups, respectively, via labile or stable linkages. 
The high-fidelity, catalyst-free bioorthogonal crosslinking reaction between these pairs of 
macromers enabled robust crosslinking in water, phosphate buffered saline and cell culture 
media to afford tough hydrogels capable of withstanding >90% compressive strain. The 
strategic placement of labile ester linkages near the crosslinking site within this superhydrophilic 
network, accomplished by facile adjustments of the ratio of the macromers used, enabled broad 
tuning of the hydrogel disintegration rates from 2 days to >250 days that precisely matched with 
the theoretical prediction based on a first-order linkage cleavage kinetics. This platform holds 
great potential for many biomedical applications that demands cytocompatability, adequate 
mechanical integrity and precisely controlled temporal disintegration of the synthetic matrix. 
